Editas Medicine (EDIT) Capital Expenditures (2015 - 2025)

Editas Medicine (EDIT) has 11 years of Capital Expenditures data on file, last reported at $1.0 million in Q2 2025.

• On a quarterly basis, Capital Expenditures rose 176.38% year-over-year to $1.0 million in Q2 2025; TTM through Sep 2025 was -$3.5 million, a 6240.35% decrease from a year earlier, with the FY2024 full-year figure at -$3.4 million, down 200.93% from the prior year.
• Capital Expenditures for Q2 2025 stood at $1.0 million, up from -$1.0 million in the prior quarter.
• Over the last five years, Capital Expenditures for EDIT reached as high as $2.3 million in Q2 2021 and fell as low as -$3.5 million in Q4 2024.
• Historically, Capital Expenditures has averaged $28833.3 across 5 years, with a median of $262500.0 in 2022.
• On a YoY basis, Capital Expenditures climbed as much as 381.37% in 2022 and fell as far as 6458.06% in 2022.
• Year by year, Capital Expenditures stood at $31000.0 in 2021, then plunged by 6458.06% to -$2.0 million in 2022, then jumped by 96.09% to -$77000.0 in 2023, then slumped by 4445.45% to -$3.5 million in 2024, then jumped by 129.29% to $1.0 million in 2025.
• Per Business Quant data, the three most recent Capital Expenditures figures were $1.0 million in Q2 2025, -$1.0 million in Q1 2025, and -$3.5 million in Q4 2024.